Skip to main content
Przejdź do strony domowej Komisji Europejskiej (odnośnik otworzy się w nowym oknie)
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

Novel health care strategies for melanoma in children, adolescents and young adults

CORDIS oferuje możliwość skorzystania z odnośników do publicznie dostępnych publikacji i rezultatów projektów realizowanych w ramach programów ramowych HORYZONT.

Odnośniki do rezultatów i publikacji związanych z poszczególnymi projektami 7PR, a także odnośniki do niektórych konkretnych kategorii wyników, takich jak zbiory danych i oprogramowanie, są dynamicznie pobierane z systemu OpenAIRE .

Rezultaty

Partner registration status (odnośnik otworzy się w nowym oknie)

List of partners identified in level of involvement.

Policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting 1 (odnośnik otworzy się w nowym oknie)

Report on policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting

Immuno-Ped initiation package (odnośnik otworzy się w nowym oknie)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.

Standardized protocols for tumor tissue processing (odnośnik otworzy się w nowym oknie)

Document detailing the standardized protocols for tumor tissue processing (inclusion, orientation of the sample, sectioning, etc)

Dissemination & communication plan 1 (odnośnik otworzy się w nowym oknie)

Document describing the dissemination and communication plan

Project Management Plan (odnośnik otworzy się w nowym oknie)

Document describing the management plan for MELCAYA project

Plan for ethic-legal monitoring & ethical submissions 1 (odnośnik otworzy się w nowym oknie)

Document detailing the plan for ethic-legal monitoring & ethical submissions

Common work plan for scientific collaboration under the ‘Understanding’ cluster (odnośnik otworzy się w nowym oknie)

Report on the common work plan for scientific collaboration under the ‘Understanding’ cluster

NevustoMel initiation package (odnośnik otworzy się w nowym oknie)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.

Patient engagement plan (odnośnik otworzy się w nowym oknie)

Detailed plan for patient engagement

AI-MEL initiation package (odnośnik otworzy się w nowym oknie)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.AI-MEL study protocol will include information about how humans will maintain meaningful control over the decision-making process for the use of the prediction and diagnostic tool to be developed in the project.

Plan for ethic-legal monitoring & ethical submissions 2 (odnośnik otworzy się w nowym oknie)

Document detailing the plan for ethic-legal monitoring & ethical submissions

Conclusions of common annual meeting of the ‘Understanding’ cluster 1 (odnośnik otworzy się w nowym oknie)

Report on the conclusions of common annual meeting of the ‘Understanding’ cluster

Precis-mel initiation package (odnośnik otworzy się w nowym oknie)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.The study protocol will include information about how humans will maintain meaningful control over the decision-making process for the use of the prediction and diagnostic tool to be developed in the project. No further deliverables will be required.

Quality Assurance and Risk Management Plan (odnośnik otworzy się w nowym oknie)

Document detailing the Quality Assurance and Risk Management Plan

ExpoMel initiation package (odnośnik otworzy się w nowym oknie)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.

Mol-Mel initiation package (odnośnik otworzy się w nowym oknie)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.

Common video and/or a common cluster brochure (odnośnik otworzy się w nowym oknie)

Video and/or common cluster brochure of the projects included in the Mission Cancer Cluster 'Understanding'.

Project Website (odnośnik otworzy się w nowym oknie)

MELCAYA webpage with public and private domains

Online and media presence 1 (odnośnik otworzy się w nowym oknie)

Document with the summary of all on line MELCAYA post, citations and interactions

Data Management Plan 1 (odnośnik otworzy się w nowym oknie)

Document detailing the Data Management PlanThe preparation of the Data Management Plan will include a common chapter onthe ‘Understanding’ cluster. The aim of the chapter is to addresscommonalities in data standards, data validation, data protection andfostering data exchange, in particular when it comes to sharing project datawith a future federated UNCAN.eu data platform. Therefore, interactions areenvisaged with the 4.UNCAN.eu (http://uncaninitiative.eu/) coordination andsupport action which is preparing a blueprint for UNCAN.eu.

Publikacje

Braf-mutant Schwann cells divert to a repair phenotype to induce congenital demyelinating neuropathy (odnośnik otworzy się w nowym oknie)

Autorzy: Elise Marechal, Patrice Quintana, Daniel Aldea, Grégoire Mondielli, Nathalie Bernard-Marissal, Mathias Moreno, Valérie Delague, Lauren A. Weiss, Anne Barlier, Heather C. Etchevers
Opublikowane w: bioRxiv, 2024, ISSN 1531-6386
Wydawca: bioRxiv
DOI: 10.1101/2024.04.24.590951

Wyszukiwanie danych OpenAIRE...

Podczas wyszukiwania danych OpenAIRE wystąpił błąd

Brak wyników

Moja broszura 0 0